NWI Management LP Takes Position in Waters Corporation $WAT

NWI Management LP bought a new position in Waters Corporation (NYSE:WAT) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 19,489 shares of the medical instruments supplier’s stock, valued at approximately $5,804,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. California Public Employees Retirement System boosted its stake in Waters by 25.4% during the first quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock valued at $41,222,000 after buying an additional 28,074 shares during the last quarter. Banque Cantonale Vaudoise increased its stake in Waters by 329.0% in the 4th quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock worth $1,631,000 after acquiring an additional 3,293 shares during the last quarter. Rockefeller Capital Management L.P. increased its stake in Waters by 106.7% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,751 shares of the medical instruments supplier’s stock worth $1,045,000 after acquiring an additional 1,420 shares during the last quarter. Ramsay Stattman Vela & Price Inc. purchased a new stake in shares of Waters during the 1st quarter worth approximately $942,000. Finally, M&T Bank Corp boosted its position in shares of Waters by 1,662.4% during the 4th quarter. M&T Bank Corp now owns 64,273 shares of the medical instruments supplier’s stock valued at $24,413,000 after acquiring an additional 60,626 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Waters Stock Down 0.7%

NYSE WAT opened at $377.75 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average of $369.30 and a two-hundred day moving average of $345.48. The firm has a market capitalization of $37.09 billion, a price-to-earnings ratio of 48.00, a PEG ratio of 2.28 and a beta of 1.20. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15.

Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the business posted $2.25 earnings per share. The business’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, analysts predict that Waters Corporation will post 14.51 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on WAT. Bank of America boosted their price target on shares of Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 2nd. JPMorgan Chase & Co. increased their price objective on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Piper Sandler started coverage on shares of Waters in a report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 target price on the stock. The Goldman Sachs Group increased their price target on shares of Waters from $380.00 to $425.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Evercore reiterated an “outperform” rating and issued a $410.00 price target on shares of Waters in a research report on Monday, July 6th. Three research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, Waters presently has an average rating of “Moderate Buy” and an average target price of $401.60.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.